Concepedia

Charu Sabharwal

CS

Statistics

Publications

5

Citations

911

H-Index

5

Active since

2020

Affiliations

Pfizer (United States)(Current)

Johns Hopkins University

SUNY Upstate Medical University

Meridian Clinical Research

Charu Sabharwal is an author at Pfizer (United States) specializing in immunodeficiencies, infection control, and precision vaccinology.

ORCID

Top concepts

Publications per year

2020–2023

5

Publications

5

Evaluation of the BNT162b2 Covid-19 Vaccine in Children 5 to 11 Years of Age

Emmanuel B. Walter, Kawsar R. Talaat, Charu Sabharwal et al. · New England Journal of Medicine · 2021 · 611 citations · Full text

Pivotal Phase 3 Randomized Clinical Trial of the Safety, Tolerability, and Immunogenicity of 20-Valent Pneumococcal Conjugate Vaccine in Adults Aged ≥18 Years

Brandon Essink, Charu Sabharwal, Kevin Cannon et al. · Clinical Infectious Diseases · 2021 · 154 citations · Full text

Evaluation of BNT162b2 Covid-19 Vaccine in Children Younger than 5 Years of Age

Flor M. Muñoz, Lawrence Sher, Charu Sabharwal et al. · New England Journal of Medicine · 2023 · 96 citations · Full text

Efficacy of a 4-Antigen <i>Staphylococcus aureus</i> Vaccine in Spinal Surgery: The <i>STaphylococcus aureus</i> suRgical Inpatient Vaccine Efficacy (STRIVE) Randomized Clinical Trial

Hamid Hassanzadeh, James Baber, Elizabeth Begier et al. · Clinical Infectious Diseases · 2023 · 35 citations · Full text

3. Phase 3 Pivotal Evaluation of 20-valent Pneumococcal Conjugate Vaccine (PCV20) Safety, Tolerability, and Immunologic Noninferiority in Participants 18 Years and Older

Brandon Essink, Charu Sabharwal, Xia Xu et al. · Open Forum Infectious Diseases · 2020 · 15 citations · Full text

, , +20

1–5 of 5